Bleeding complications during percutaneous coronary intervention

Area of Science:

• Cardiology
• Pharmacology
• Interventional Procedures

Background:

• Bleeding complications persist as a significant challenge in interventional cardiology despite recent advancements.
• Effective antithrombotic therapy is crucial for preventing thrombotic events but increases bleeding risk.

Purpose of the Study:

• To review bleeding complications associated with antithrombotic agents used in interventional cardiology.
• To evaluate the safety profile of alternative anticoagulants, such as bivalirudin and enoxaparin, compared to heparin.

Main Methods:

• Review of current literature on antithrombotic agents and bleeding risk in interventional cardiology.
• Comparative analysis of bleeding complications associated with heparin, glycoprotein IIb/IIIa inhibitors, aspirin, clopidogrel, bivalirudin, and enoxaparin.

Main Results:

• Various antithrombotic agents contribute to bleeding risk in interventional cardiology procedures.
• Alternative anticoagulants like bivalirudin and enoxaparin are being investigated for potential bleeding advantages over traditional heparin regimens.

Conclusions:

• Careful selection of antithrombotic agents and procedural techniques is essential for mitigating bleeding risk.
• Further research is needed to fully elucidate the bleeding profiles of alternative anticoagulants in diverse patient populations undergoing interventional cardiology.